SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001140361-22-034687
Filing Date
2022-09-26
Accepted
2022-09-26 16:18:49
Documents
2
Group Members
COREY GOODMANROBERT ADELMANVENBIO GLOBAL STRATEGIC GP III, L.P.VENBIO GLOBAL STRATEGIC GP III, LTD.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A brhc10042253_sc13ga.htm SC 13G/A 163806
2 EXHIBIT 1 brhc10042253_ex1.htm EX-1 16008
  Complete submission text file 0001140361-22-034687.txt   181479
Mailing Address 1700 OWENS STREET SUITE 595 SAN FRANCISCO CA 94158
Business Address 1700 OWENS STREET SUITE 595 SAN FRANCISCO CA 94158 415-522-0100
venBio Global Strategic Fund III, L.P. (Filed by) CIK: 0001739920 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 230 THIRD AVE., 6TH FLOOR WALTHAM MA 02451
Business Address 230 THIRD AVE., 6TH FLOOR WALTHAM MA 02451 8445311834
CinCor Pharma, Inc. (Subject) CIK: 0001868734 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-93228 | Film No.: 221265920
SIC: 2834 Pharmaceutical Preparations